The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

Technical improvements have made transplantation safer. Standard chemotherapy cures a small minority of patients with acute myeloid leukemia ... Golgi apparatus to the cell surface, where the ...

Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

which involves a 67-year-old man who had been living with HIV for 14 years when he was diagnosed with AML. He underwent reduced-intensity conditioning therapy followed by a stem cell transplant from ...

The cornea is the clear, outermost layer of the eye. Its outer border, the limbus, contains a large volume of healthy stem ...

Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...

First Mouse With Two Male Parents to Reach Adulthood Jan. 28, 2025 — A team of stem cell scientists have ... for the treatment of acute myeloid leukemia and ... How Breast Cancer Cells Survive ...

Technical improvements have made transplantation safer. Standard chemotherapy cures a small minority of patients with acute myeloid leukemia. Postremission therapy is needed for cure. Cytogenetic ...